Everolimus Combined With Octeotride LAR to Treat Advanced GI NET (EVERLAR)
This study is currently recruiting participants.
Verified April 2012 by Grupo Espanol de Tumores Neuroendocrinos
Sponsor:
Grupo Espanol de Tumores Neuroendocrinos
Information provided by (Responsible Party):
Grupo Espanol de Tumores Neuroendocrinos
ClinicalTrials.gov Identifier:
NCT01567488
First received: March 26, 2012
Last updated: April 10, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |